Viewing Study NCT01510561


Ignite Creation Date: 2025-12-24 @ 12:36 PM
Ignite Modification Date: 2026-02-20 @ 4:44 PM
Study NCT ID: NCT01510561
Status: WITHDRAWN
Last Update Posted: 2021-08-19
First Post: 2012-01-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Fractionated 90Y-hPAM4 Plus Gemcitabine in Pancreatic Cancer Patients Receiving at Least 2 Prior Therapies.
Sponsor: Gilead Sciences
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2012-03
Start Date Type: ACTUAL
Primary Completion Date: 2015-06
Primary Completion Date Type: ESTIMATED
Completion Date: 2015-09
Completion Date Type: ACTUAL
First Submit Date: 2012-01-05
First Submit QC Date: None
Study First Post Date: 2012-01-16
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-08-12
Last Update Post Date: 2021-08-19
Last Update Post Date Type: ACTUAL